Working… Menu

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01121848
Recruitment Status : Completed
First Posted : May 12, 2010
Last Update Posted : October 27, 2014
Information provided by (Responsible Party):